NCT00318721
Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar No drug interventions prevention Not Available completed NCT01138956
Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine basic_science Not Available unknown_status NCT04342715
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis Not Available Not Available recruiting NCT01980199
Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan treatment 2 terminated NCT03269006
Improved Case Detection and Vector Control for Visceral Leishmaniasis No drug interventions prevention Not Available completed NCT00628719
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis treatment 3 completed NCT02071758
Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers prevention 1 completed NCT02011958
Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. treatment 3 completed NCT02148822
Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia No drug interventions Not Available Not Available completed NCT01766830
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) No drug interventions diagnostic Not Available completed NCT00486382
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India No drug interventions treatment 1 completed NCT01240473
A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh No drug interventions treatment Not Available completed NCT00255567
Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis treatment 3 completed NCT00696969
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis treatment 3 completed NCT00604955
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis treatment 4 completed NCT00342823
Immunogenetics of Visceral Leishmaniasis No drug interventions Not Available Not Available completed NCT00832208
Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL treatment 2 terminated NCT01310738
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil treatment 4 terminated NCT02431143
Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa treatment 2 completed NCT02839603
Asymptomatic Leishmania Infection in HIV Patients No drug interventions Not Available Not Available terminated NCT01032187
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children treatment 4 completed NCT05426577
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure No drug interventions Not Available Not Available unknown_status NCT01069198
A Community Trial for Visceral Leishmaniasis (VL) prevention Not Available completed NCT00310505
Amphotericin B Treatment in Visceral Leishmaniasis No drug interventions treatment Not Available completed NCT01122771
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh treatment 3 completed NCT04003532
LAMP Assay for the Diagnosis of Visceral Leishmaniasis No drug interventions Not Available Not Available completed NCT01566552
Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis treatment 4 unknown_status NCT03636659
Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition treatment 1 completed NCT05386875
Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya No drug interventions Not Available Not Available recruiting NCT06118749
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study No drug interventions Not Available Not Available not_yet_recruiting NCT03929016
Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects No drug interventions treatment 1 completed NCT00370825
Combination Chemotherapy for the Treatment of Indian Kala-Azar treatment 2 completed NCT01328457
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh treatment Not Available completed NCT00629031
An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis treatment 3 completed NCT01360762
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study prevention 3 completed NCT00497601
A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar treatment 2 completed NCT03129646
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa treatment 3 completed NCT00216346
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis treatment 3 completed NCT05602610
Clinical Prognostic Score to Predict Relapse in VL No drug interventions Not Available Not Available recruiting NCT00371995
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar treatment 2 completed NCT03646981
Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa No drug interventions Not Available Not Available completed NCT05449717
Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan No drug interventions Not Available Not Available recruiting NCT00876824
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar treatment 3 completed NCT00523965
Combination Therapy in Indian Visceral Leishmaniasis treatment 3 completed NCT03013673
Predicting Visceral Leishmaniasis in HIV Infected Patients No drug interventions Not Available Not Available terminated NCT00381394
A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. treatment 2 completed NCT00001169
Clinical Investigation of Infections Due to Leishmanial Parasites No drug interventions Not Available Not Available completed